1999

Jul 6, 1999
Guidant Announces CE Mark Approval to Market its ACS MULTI-LINK TRISTAR Coronary Stent Systems

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received CE Mark approval for its ACS MULTI-LINK...

Jun 23, 1999
FDA Advisory Panel Unanimously Recommends Approval of Guidant''s ANCURE(tm) System for Minimally Invasive Treatment of Abdominal Aortic Aneurysms

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiovascular and vascular therapy, announced today that the Circulatory System Devices Panel of the Medical Devices...

Jun 4, 1999
Guidant Announces U.S. Market Releaseof PULSAR and PULSAR MAX Dual-Sensor Pacemaker Systems

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced the U.S. market release of the PULSAR(tm) and PULSAR MAX...

May 18, 1999
Guidant Announces CE Mark Approval to Market its ACS MULTI-LINK RX ULTRA Coronary Stent System For Saphenous Vein Grafts

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received CE Mark approval for the ACS MULTI-LINK...

May 17, 1999
Guidant Announces Re-election of Directors

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiovascular therapy, announced that at the company(tm)s Annual Meeting of Shareholders on , Guidant(tm)s...

Show 5102550100 per page
Top